|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Full Time MBA |
Denied without Interview
|
Round 4 | 2024 | 720 GMAT Classic | 7 | Finance: Investment Banking | United States |
10 May 2024 02:23 PM
|
|
| Full Time MBA |
Denied with Interview
|
Round 2 | 2024 | 315 GRE | 3.1 | 7 | Consulting | United States |
10 May 2024 12:42 PM
|
| Full Time MBA |
Interviewed
|
Round 2 | 2024 | 730 GMAT Classic | 10 | Finance | Canada |
05 May 2024 01:24 PM
|
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 327 GRE | 3.1 | 3 | Consulting | India |
04 May 2024 09:11 PM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2024 | Waiver | 3.5 | 6 | Finance | Chile |
20 Apr 2024 04:55 AM
|
| Full Time MBA |
Admitted, ($)
|
Round 2 | 2024 | 7 | Technology | China |
16 Apr 2024 12:50 PM
|
||
| Full Time MBA |
Admitted, ($$)
|
Round 3 | 2024 | 158 EA | 3.4 | 5 | Consulting | United States |
10 Apr 2024 12:52 PM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2024 | 770 GMAT Classic | 4 | 3 | Other | Ukraine |
10 Apr 2024 04:01 AM
|
| Full Time MBA |
Admitted from WL, ($)
|
Round 2 | 2024 | 750 GMAT Classic | 3.8 | 2 | Consulting | United States |
05 Apr 2024 12:03 PM
|
| Full Time MBA |
Denied with Interview
|
Round 2 | 2024 | 306 GRE | 2.9 | 7 | Consulting | United States |
01 Apr 2024 01:35 PM
|
| Full Time MBA |
Admitted, ($$)
|
Round 1 | 2024 | 730 GMAT Classic 740 GMAT Classic |
3.8 | 5 | Non-Profit and Government | India |
01 Apr 2024 08:46 AM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2024 | 770 GMAT Classic | United States |
29 Mar 2024 02:33 AM
|
|||
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2024 | 740 GMAT Classic | 3.3 | 4 | Consulting | Viet Nam |
27 Mar 2024 12:19 PM
|
| Full Time MBA |
Admitted
|
Round 1 | 2024 | 329 GRE | 3.8 | 3 | Healthcare/Pharmaceuticals | India |
26 Mar 2024 01:06 PM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 329 GRE | 3.2 | 6 | Consulting | India |
21 Mar 2024 02:40 PM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2024 | 760 GMAT Classic | 3.1 | 5 | Technology | India |
21 Mar 2024 04:10 AM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2024 | 740 GMAT Classic | 3.2 | 5 | Consulting | India |
19 Mar 2024 08:51 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 328 GRE | 3.7 | 4 | Pharmaceuticals and Biotech | India |
19 Mar 2024 01:35 AM
|
| Full Time MBA |
Waitlisted without Interview
|
Round 2 | 2024 | 720 GMAT Classic | 7.5 | 4 | Consulting | Brazil |
14 Mar 2024 06:22 PM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2024 | 720 GMAT Classic | 3 | Healthcare/Pharmaceuticals | United States |
14 Mar 2024 02:21 PM
|